Stories & News

LRA Funding Helps Identify Uncontrolled Blood Pressure as Particular Risk in Lupus

March, 2019 New results partially funded by the Lupus Research Alliance found that people with systemic lupus erythematosus have almost...

Patients with Lupus Nephritis-Related Kidney Disease Are Living Longer

March 28, 2019 A new study published this March in Arthritis & Rheumatology found that deaths among patients with end-stage...

NOT TOO LATE: Join Our 15th Annual Advocate for Lupus Research Day – THROUGH NEXT WEEK!

Lupus purple was seen throughout the Capitol this week when advocates representing the Lupus Research Alliance visited Congress to...

Study Finds Mycophenolate Mofetil Comparable to Standard Treatment for Pediatric Lupus Nephritis

March 19, 2019 A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...

Thank you 2019 Half-Marathon Team Life Without Lupus!

Thanks to the Lupus Research Alliance Team Life Without Lupus, with runners who pounded the pavements at the United...

LRA-Supported Researchers Developed a Model to Predict Full-Blown Lupus Nephritis Down the Road

A new study funded by the Lupus Nephritis Trials Network with support from the Lupus Research Alliance has proposed...

Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Retrospective Study on Prevalence, Associated Factors and Outcome

A new study published in the peer-reviewed journal Lupus shows that lupus can cause damage to the peripheral nervous...

Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation

NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...

Frailty Measure Predicts Mortality Risk Among People with Lupus

March 11, 2019 A new study published in Arthritis & Rheumatology by many top lupus clinicians found that a frailty...

Lupus Therapeutics to Test Potential Treatment for Lupus in Takeda Collaboration

New York, NY– March 1. The Lupus Research Alliance and clinical affiliate, Lupus Therapeutics will partner with Takeda Pharmaceutical Company...

Positive Early Results for BIIB059 as New Treatment Strategy

February 28, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...

LRA-funded Research Backs New Lupus Nephritis Clinical Trial

February 28, 2019 The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...